BDBM555298 3-(((6-chloro-2-cyclopropyl-1-(1-(6-(3-(3′,6′-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9′-xanthen]-5-yl)ureido)hexyl)-1H-pyrazol-4-yl)-7-fluoro-1H-indol-3-yl)thio)-2-fluoro benzoic acid sodium salt ::US11344533, Compound 1-131

SMILES OC(=O)c1cccc(Sc2c(C3CC3)n(-c3cnn(CCCCCCNC(=O)Nc4ccc5c(c4)C(=O)OC54c5ccc(O)cc5Oc5cc(O)ccc45)c3)c3c(F)c(Cl)ccc23)c1F

InChI Key InChIKey=AKPNMORVNGXMAR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 555298   

TargetAutotaxin(Human)
Sabre Therapeutics

US Patent
LigandPNGBDBM555298(US11344533, Compound 1-131 | 3-(((6-chloro-2-cyclo...)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
Go to US Patent